Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres
0 citationsThe Lancet Infectious Diseases
Mark Howard
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
40Publications signalées
1069Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
COVID-19 Clinical Research StudiesComplement system in diseasesGenetic Syndromes and ImprintingSARS-CoV-2 and COVID-19 ResearchEpigenetics and DNA Methylation
Publications récentes
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
11 citationsThe Lancet Infectious Diseases
Collectin-11 regulates osteoclastogenesis and bone maintenance via a complement-dependent mechanism
Mark Howard, Conrad A. Farrar, Christopher L. Nauser, Yusun Jeon et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jaffar Abbas et autres
3 citationsEClinicalMedicine
S3896 HIV Screening Prior to Immune - Suppressive Therapy for Inflammatory Bowel Diseases: Essential or Optional?
Tarek Odah, Mark Howard, Ewa Wysokinska, Steven Attia et autres
0 citationsThe American Journal of Gastroenterology
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Sandercock, Janet Darbyshire, David L. DeMets, Robert Fowler et autres
11 citationsNature Communications
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Saul N. Faust, Richard Haynes, Christine E. Jones, Natalie Staplin et autres
40 citationsThe Lancet Child & Adolescent Health
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, Jonathan R. Abbas et autres
41 citationsThe Lancet Diabetes & Endocrinology
Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland
Valeria Scagliotti, Maria Lillina Vignola, Thea L. Willis, Mark Howard et autres
7 citationseLife
Author response: Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland
Valeria Scagliotti, Maria Lillina Vignola, Thea L. Willis, Mark Howard et autres
0 citations
Optimizing Outcomes After Reverse Total Shoulder Arthroplasty: Rehabilitation, Expected Outcomes, and Maximizing Return to Activities
Mark Howard, Nicholas A. Trasolini, Brian R. Waterman
28 citationsCurrent Reviews in Musculoskeletal Medicine
Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland
Valeria Scagliotti, Maria Lillina Vignola, Thea L. Willis, Mark Howard et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.